Sukumar Nagendran, Director of Solid Biosciences SLDB, has filed 1 purchase and 8 sales on the open market. Over the past 12 months that comes to a net sale of $4.1M. The latest trade was on 06/10.

SN

SN

Sukumar Nagendran

Director

Company

Solid Biosciences SLDB

First filing

23/01/04

Trades

35 trades

Buys / sales

1 / 8

12-month net buying

−$4.1M

Last trade

06/10

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Taysha Gene TherapiesTSHA	Open-market sale10b5-1 plan	04/10	04/13	200,000 sh	$4.46	$892,000	−15.0%
Taysha Gene TherapiesTSHA	Open-market sale	01/23–01/26	01/27	116,050 sh2 trades	$4.72avg.	$547,468.98	−8.1%
Taysha Gene TherapiesTSHA	Open-market sale10b5-1 plan	01/12	01/14	200,000 sh	$4.71	$942,000	−16.6%
Taysha Gene TherapiesTSHA	Open-market sale	25/11/28–25/12/01	25/12/01	370,172 sh2 trades	$4.58avg.	$1,695,905.72	−26.9%
Taysha Gene TherapiesTSHA	Open-market sale10b5-1 plan	25/09/10	25/09/12	200,000 sh	$3.23	$646,000	−16.6%
Taysha Gene TherapiesTSHA	Open-market sale	25/08/21	25/08/22	57,054 sh	$2.85	$162,603.9	−4.7%
Taysha Gene TherapiesTSHA	Open-market buy	23/05/16	23/05/18	5,000 sh	$0.68	$3,400	+17.1%